Objective: To investigate the evaluation of pelvic lymph node metastasis (PLNM) in patients with cervical cancer by a comprehensive nomogram based on radiomics signature extracted from the union diffusion kurtosis imaging (DKI) and T2-weighted imaging (T2WI) combined with fig.
Methods We obtained clinical characteristics, pathologic characteristics, and hematological inflammatory variables for all 510 included patients. Meanwhile, a total of 1316 radiomics features were extracted from both T2WI and DKI images, respectively. The least absolute shrinkage and selection operator (LASSO) method was used to select the relevant features for PLNM prediction with non-zero coefficients. The Receiver operating characteristic curves (ROCs) were established using radiomics signatures derived from DKI, T2WI, and joint DKI and T2WI, respectively, to evaluate the performance of distinguishing the cervical cancer patients with PLNM. Univariate and multivariate analyses were used to investigate the independent predictors associated with PLNM in clinical hematological inflammatory variables. A comprehensive nomogram was built by combining the selected radiomic features and clinical hematological inflammatory parameters based on multivariate logistic regression for PLNM prediction in patients with cervical cancer.
Results For DKI, T2WI, and joint DKI and T2WI, the radiomics signatures yielded an AUC of 0.895 (95%CI, 0.823-0.967) vs 0.893 (95%CI, 0.819-0.966) vs 0.933 (95%CI, 0.880-0.986), and 0.889 (95%CI, 0.770-1.000) vs 0.889 (95%CI, 0.758-1.000) vs 0.912 (95%CI, 0.813-1.000) respectively in the primary and validation cohorts. Univariate and multivariate analyses showed that SII (p<0.001) was an independent predictor of PLNM in patients with cervical cancer. The clinical-radiomics model integrating SII and the radiomics signatures from joint DKI and T2WI yielded a higher AUC than the clinical model or radiomics model alone.
Conclusions: The clinical-radiomics comprehensive nomogram based on the radiomics signatures from the joint DKI and T2WI and a readily available hematological factor (SII) showed superior performance in the evaluation of the risk of PLNM than the single clinical model or radiomics model in cervical cancer.
If you have any questions about submitting your review, please email us at [email protected].